https://www.egetis.com/investors-content/ 2023-11-24T15:35:08+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-may-2023/ 2023-05-17T11:54:45+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-january-2023/ 2023-05-17T11:54:55+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-december-2022/ 2023-05-17T11:57:00+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-november-2022/ 2023-05-17T11:57:34+00:00 https://www.egetis.com/investors-content/redeye-interview-with-ceo-nicklas-westerholm/ 2023-05-17T11:58:00+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-october-2022/ 2023-05-17T11:58:33+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-september-2022/ 2023-05-17T11:59:16+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-august-2022/ 2023-05-17T12:00:08+00:00 https://www.egetis.com/investors-content/redeye-interview-with-ceo-after-q2-report/ 2023-05-17T12:00:30+00:00 https://www.egetis.com/investors-content/pareto-interview-with-peder-walberg-and-nicklas-westerholm/ 2023-05-17T12:00:53+00:00 https://www.egetis.com/investors-content/nicklas-westerholm-presenting-at-abgsc-life-science-summit/ 2023-05-17T12:01:20+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-may-2022/ 2023-05-17T13:16:33+00:00 https://www.egetis.com/investors-content/peder-walberg-presenting-at-redeye-orphan-drugs-event/ 2023-05-17T13:16:48+00:00 https://www.egetis.com/investors-content/handelsbanken-healthy-hour/ 2023-05-17T13:17:06+00:00 https://www.egetis.com/investors-content/redeye-interview-with-ceo-after-q4-report-17-february-2022/ 2023-05-17T13:17:21+00:00 https://www.egetis.com/investors-content/webcast-regarding-us-regulatory-path/ 2023-05-17T13:17:43+00:00 https://www.egetis.com/investors-content/webcast-regarding-marketing-authorisation-application-for-emcitate/ 2023-05-17T13:18:05+00:00 https://www.egetis.com/investors-content/redeye-life-science-day/ 2023-05-17T13:18:30+00:00 https://www.egetis.com/investors-content/redeye-interview-with-the-ceo-in-connection-with-the-q3-report/ 2023-05-17T13:18:54+00:00 https://www.egetis.com/investors-content/interview-with-peder-walberg-at-pareto-operative-director-of-the-board-and-founder-of-rare-thyroid-therapeutics-in-swedish/ 2023-05-17T13:19:10+00:00 https://www.egetis.com/investors-content/presentation-at-penser/ 2023-05-17T13:19:29+00:00 https://www.egetis.com/investors-content/the-pareto-healthcare-conference-presentation/ 2023-05-17T13:19:56+00:00 https://www.egetis.com/investors-content/abgsc-life-science-summit/ 2023-05-17T13:20:12+00:00 https://www.egetis.com/investors-content/erik-penser-bank-commercialization-of-pharmaceuticals/ 2023-05-17T13:21:31+00:00 https://www.egetis.com/investors-content/aktiedagen-in-swedish/ 2023-05-17T13:21:51+00:00 https://www.egetis.com/investors-content/redeye-orphan-drugs/ 2023-05-17T13:22:12+00:00 https://www.egetis.com/investors-content/interview-with-dr-thomas-lonngren-nominated-cob-and-ceo-nicklas-westerholm/ 2023-05-17T13:22:30+00:00 https://www.egetis.com/investors-content/interview-with-ceo-nicklas-westerholm-at-redeye/ 2023-05-17T13:22:58+00:00 https://www.egetis.com/investors-content/interview-with-ceo-nicklas-westerholm-in-pareto-tv/ 2023-05-17T13:23:35+00:00 https://www.egetis.com/investors-content/company-investor-and-analyst-presentation-acquisition-of-rtt/ 2023-05-17T13:23:51+00:00 https://www.egetis.com/investors-content/acquisition-of-rare-thyroid-therapeutics-interview-at-redeye/ 2023-05-17T13:24:07+00:00 https://www.egetis.com/investors-content/egetis-and-rtt-agree-to-join-forces/ 2023-05-17T13:24:37+00:00 https://www.egetis.com/investors-content/pareto-healthcare-seminar-company-presentation/ 2023-05-17T13:24:58+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-february-2023/ 2023-05-17T13:25:14+00:00 https://www.egetis.com/investors-content/penser-bolagsdag-stockholm/ 2023-05-17T13:25:34+00:00 https://www.egetis.com/investors-content/interim-report-january-june-2023/ 2023-05-17T13:25:59+00:00 https://www.egetis.com/investors-content/interim-report-january-september-2023/ 2023-05-17T13:26:13+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-june-2023-2/ 2023-11-24T15:31:49+00:00 https://www.egetis.com/investors-content/egetis-presentation-investor-and-analyst-webinar-29-june-2023/ 2023-11-24T15:33:19+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-july-2023/ 2023-11-24T15:33:42+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-august-2023/ 2023-11-24T15:34:17+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-october-2023/ 2023-11-24T15:34:40+00:00 https://www.egetis.com/investors-content/egetis-corporate-presentation-november-2023/ 2023-11-24T15:35:08+00:00